Key words: cyclosporin; erythrocyte deformability; fibrinogen; haemorheology; plasma viscosity; renal Background. Abnormalities in blood rheology may be factors contributing to cardiovascular complications transplantation and the progression of renal failure in kidney allograft recipients. The haemorheological variables haematocrit, fibrinogen, whole blood viscosity, plasma viscos-Introduction ity, erythrocyte aggregation tendency and fluidity were measured in 27 cyclosporin A (CyA)-treated patients Cardiovascular complications are very common in who had received a renal graft at least 6 months renal transplant patients. Several cardiovascular risk previously. Their creatinine clearance was in the range factors, such as hyperlipidaemia, hypertension and of 12-92 ml/min/1.73 m2 (mean 55±19). The values insulin resistance, have also been identified in these were compared with those obtained from a control patients. group comprising 20 healthy subjects matched accordThere are some reports indicating that certain ing to age, sex and smoking habits.
T. Linde et al. 1526 patient had been in a supine position for 10 min. Mean progression of renal failure. The aim of the present arterial pressure (MAP) was calculated from diastolic presstudy was to elucidate whether haemorheological sure plus one-third of the pulse pressure.
abnormalities also exist in patients with a functioning Blood samples were obtained from an antecubital vein. renal graft.
The haematocrit was analysed by micro-haematocrit centrifugation at 11 000 g for 5 min without correction for trapped plasma.
Patients and methods
Within 20 min after blood collection, the haemorheological variables were assessed at 37°C in a Low Shear 30 rotational viscometer (Contraves AG, Zü rich, Switzerland). Plasma
Study population
viscosity was analysed at a shear rate of 38 s−1 and apparent whole blood viscosity at 100 s−1 at native haematocrit. A total of 27 renal transplant recipients were investigated at the time-point for the inclusion in a trial aimed to examine As proposed by the International Committee for Standardization in Haematology [11] , erythrocyte aggregathe effects of a lipid-lowering drug (ALERT Study). The patients were renal or combined renal and pancreas trans-tion tendency was assessed as whole blood viscosity at native haematocrit at a shear rate of 1 s−1 and corrected for plant subjects >6 months previously and at an age of between 30 and 75 years. The total cholesterol level had to haematocrit and plasma viscosity. The unit for erythrocyte aggregation is dimensionless. be in the range 4.0-9.0 mmol/l and, in the case of a former myocardial infarction, in the range 4.0-7.0 mmol/l. All Erythrocyte deformability was assessed as the fluidity (inverse viscosity) of red blood cells separated from plasma patients were maintained with cyclosporin A (CyA) (Sandimmun Neoral@, Novartis) combined with steroids in and buffy coat and resuspended in isotonic phosphatebuffered saline (pH 7.4) to a haematocrit of 55%. A shear all but one case. No patient had been treated due to an acute rejection during the last 3 months. Liver enzymes and total rate of 1 s−1 was used.
Plasma fibrinogen was determined by rate nephelometry. bilirubin had to be less than twice the normal upper limit. No patient was on erythropoietin therapy.
Other biochemical variables were analysed using standard laboratory techniques for hospital use. Patients included had been on renal replacement therapy for 95±43 months. The primary renal diseases were chronic glomerulonephritis in 16 patients, polycystic kidney disease Statistical evaluation in four, diabetic nephropathy in four, other in two cases and unknown in one. Twenty of the patients were recipients of Values are presented as means±SD. The statistical package cadaveric transplants, and the remaining seven had received StatView@SE+Graphics (Abacus Concepts, Inc, USA) was transplants from living donors. Three of the patients with used for all statistical calculations. Unpaired two-tailed tdiabetes also had a pancreas graft.
test, simple, stepwise multiple and multiple regression anaPhysical and laboratory characteristics of the patients were lyses were used. The level of statistic significance was set compared with data obtained from a group of 20 healthy at P<0.05. volunteers matched according to age, sex and smoking habits. All these subjects were employees at the medical centre or their relatives. Baseline data of transplant recipients and the
Results
normal subjects are given in Table 1 .
Compared with the control group, the kidney transLaboratory methods plant recipients had an increased BMI and MAP. Serum trigycerides were increased and high density Body mass index (BMI ), as a measurement of obesity, was lipoprotein ( HDL)-cholesterol decreased, whereas no defined as body weight in kilograms divided by squared length in metres. Blood pressure was measured after the statistically significant difference was detected in total serum cholesterol. The creatinine clearance varied gen was positively correlated with BMI, erythrocyte aggregation tendency and the plasma viscosity between 12 and 92 ml/min/1.73 m2 and serum creatinine was increased in the transplant recipients. The ( Figure 1 ). mean CyA concentration in blood, 12 h after intake, was within the therapeutic range chosen in our unit.
Discussion
Albuminuria in the range 0-30 mg/day was found in 14 patients and in the range 31-300 mg/day in 12 patients. One patient had a marked albuminuria of In the present investigation, all variables measured with a known impact on blood viscosity were altered. 2 g/day ( Table 1) .
Apart from a slight increase in white blood cell The whole blood viscosity in vitro is determined mainly by the haematocrit [5] . In our patients, the mean count, no significant differences in the haematological variables measured were detected ( Table 2) .
haematocrit exceeded that in normal subjects matched according to age, sex and smoking habits, factors with All haemorheological variables differed between the two groups. The haematocrit, plasma fibrinogen, whole an impact on the haematocrit. Post-transplant erythrocytosis is relatively common in patients with a renal blood viscosity, plasma viscosity and erythrocyte aggregation tendency were increased and erythrocyte graft, and a prevalence of 6.5-35.8% has been found [12] . If a haematocrit exceeding 51% in males and 47% fluidity decreased in renal transplant recipients compared with healthy subjects (Table 3) .
in females was taken as definition of post-transplant erythrocytosis [13], the condition was found in four In the group of kidney recipients, the haemorheological variables (haematocrit, fibrinogen, whole blood (15%) of our patients. The mechanisms underlying the condition are poorly understood. In patients with viscosity, plasma viscosity, aggregation tendency and fluidity) were used as dependent variables in a stepwise chronic renal failure, the haematocrit generally decreases with decreasing renal function [14] . In the regression analysis with age, MAP, BMI, urinary albumin excretion rate, blood CyA, creatinine clearance, present group of renal transplant recipients, no correlation between graft function and haematocrit was serum triglycerides, serum cholesterol and serum HDLcholesterol as independent variables. BMI ( Figure 1) found, however. This finding may support propositions that inappropriate erythropoietin production by the and blood CyA remained positively correlated with plasma fibrinogen. Blood CyA remained positively and native kidneys or increased sensitivity of erythroid precursors explain an increased haematocrit in renal serum HDL-cholesterol negatively correlated with the whole blood viscosity. Erythrocyte aggregation tend-transplant recipients [13] .
In contrast to the findings of Koppensteiner and ency was positively correlated with serum trigycerides ( Table 4) . None of the independent variables were collaborators [15] , who recently reported haemorheological findings after renal transplantation, the plasma significantly correlated with the haematocrit, plasma viscosity or erythrocyte fluidity. viscosity was increased in our patients compared with the healthy subjects. The plasma concentration of In simple linear regression analysis, plasma fibrino- fibrinogen is an important determinant of plasma blood cells [5] , and high fibrinogen levels may, therefore, contribute to the increased erythrocyte aggregaviscosity [5] . In the present study, plasma fibrinogen was increased and correlated with the plasma viscosity, tion tendency found in the present and previous studies.
Such a proposition is supported by the finding of a indicating that increased fibrinogen levels could be one factor explaining the increased plasma viscosity in our correlation between the two variables. As in patients with type I diabetes [20] , our regression analysis indipatients.
Increased plasma levels of fibrinogen are common cates that elevated concentrations of triglycerides may be another factor of importance to erythrocyte in patients on regular dialysis [15, 16 ] . After renal transplantation, plasma fibrinogen remains elevated aggregation tendency in kidney transplant recipients.
The diameter of an erythrocyte at rest is~8 mm [15], or increases further [16 ] . Plasma fibrinogen is also known to be increased in subjects with obesity while the smallest nutritive capillaries have a diameter of 2-3 mm [21]. This implies that the ability of the [17] . In the present investigation, the patient BMI exceeded that of healthy subjects and was correlated erythrocyte to undergo deformation is of great significance for the microcirculation. Erythrocyte deformwith plasma fibrinogen. Obesity may, consequently, be a factor contributing to the increased plasma fibrinogen ability deteriorates with decreasing renal function, and is decreased in dialysis patients [8] . In the present in renal transplant recipients.
Patients on steroids and azathioprin alone [16 ] or study, erythrocyte deformability was measured as erythrocyte fluidity. This variable was decreased in the FK 506 [18] have been shown to have significantly lower fibrinogen levels than those receiving cyclospo-patients compared with the healthy subjects and was at approximately the same level as was demonstrated rin. Moreover, CyA-treated patients with aplastic anaemia experience higher fibrinogen levels than control in a previously examined group comprising pre-dialysis and haemodialysis patients [22] . Erythrocyte deformsubjects or patients with anaemia not treated with CyA [19] . In the present study, all patients were maintained ability was not correlated with graft function, and factors other than the decreased renal function conon CyA, and the CyA concentration in blood remained significantly correlated with plasma fibrinogen in the sequently seem to be the cause of the reduced deformability in the present study. The use of CyA may be stepwise multiple analysis. The R2 value obtained when blood CyA and BMI were used as independent vari-one such factor, since erythrocyte deformability has been shown to be lower in renal transplant recipients ables indicates that 40% of the variation in plasma fibrinogen is explained by variations in these two using CyA compared with those using azathioprin and prednisolone [23] . 
